Publications by authors named "G M Magnano"

Ante-mortem diagnosis of bovine tuberculosis (bTB) is based mainly on the tuberculin skin test (TST) and the ɣ-IFN release assay (IGRA). Some infected animals escape screening tests, thus, limit herd sanitation. Previous reports have suggested a predominant pattern of multi-organ lesions attributable to (the causative agent of bTB) bacteraemia.

View Article and Find Full Text PDF

We evaluated GaAs nanoparticle-concentrations in the air and on skin and surfaces in a research facility that produces thin films, and to monitored As in the urine of exposed worker. The survey was over a working week using a multi-level approach. Airborne personal monitoring was implemented using a miniature diffusion size classifier (DiSCMini) and IOM sampler.

View Article and Find Full Text PDF

Sildenafil citrate is an approved drug used for the treatment of erectile dysfunction and premature ejaculation. Despite a widespread application, sildenafil citrate shows numerous adverse cardiovascular effects in high-risk patients. Local transdermal drug delivery of this drug is therefore being explored as an interesting and noninvasive alternative administration method that avoids adverse effects arised from peak plasma drug concentrations.

View Article and Find Full Text PDF
Article Synopsis
  • Antibiotic resistance is a critical issue in healthcare and agriculture, with a focus on using biocompatible and biodegradable substances like curcumin supported by the Next Generation EU platform.
  • Encapsulating curcumin in nanobubbles (NBs) enhances its solubility, stability, and antibacterial effectiveness, particularly when activated by specific wavelengths of light.
  • The study finds that oxygen-loaded curcumin nanobubbles (Curc-Oxy-CS-NBs) significantly improve antibacterial properties, showing a drastic reduction in minimum inhibitory concentration (MIC) and effectively killing bacteria through mechanisms like ROS-induced membrane leakage.
View Article and Find Full Text PDF

Objective: Barrier creams (BCs) are marketed as locally applied medical devices or cosmetic products to protect the skin from exposure to chemicals and irritants. Generally, the mechanism of action of such products is mainly due to the formation of a superficial thin film between the skin and the irritant or sensitizer, thus reducing or totally blocking the cutaneous penetration of such agents. Specifically, studies focusing on the effectiveness of commercial protective creams to prevent nickel cutaneous penetration are extremely scarce.

View Article and Find Full Text PDF